Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Novel chiral catalytic route for Tofacitinib Citrate. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical manufacturing.
Novel chiral ligand enables high ee copper catalysis. Reduces cost in pharmaceutical intermediates manufacturing. Reliable supply chain partner.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN104945410B details asymmetric catalysis for high-purity intermediates. This method ensures scalable production and significant cost efficiency for global supply chains.
Advanced catalytic process for NEP inhibitor intermediates offering superior stereoselectivity. Discover cost-effective manufacturing solutions for complex amino acid derivatives.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover the Rh-catalyzed asymmetric hydrogenation patent CN116444412A for chiral trifluoromethyl nitrogen heterocycles. Achieve high ee values and cost reduction in pharmaceutical intermediate manufacturing with scalable solutions.
Patent CN102464681A discloses a stable chiral bidentate phosphite ligand for asymmetric synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Advanced patent CN108658831B reveals a high-yield Pd-catalyzed hydrogenation route for Brivaracetam intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN101175715B details Rh-catalyzed hydrogenation using PhanePhos for high-purity 3,3-diarylalanine intermediates, offering scalable API synthesis solutions.
Patent CN101323609A details a novel asymmetric oxidation method for high-purity PPI intermediates, offering significant cost reduction and supply chain reliability.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Novel synthesis method for Paxlovid intermediate offering high purity and scalable production capabilities for global pharmaceutical supply chains and significant cost efficiency.
Patent CN114478608A discloses Rh-catalyzed enantioselective silylation. Offers high ee values and novel structures for functional materials and pharma intermediates.
Patent CN115991667A details a novel Pd-catalyzed method for synthesizing chiral 3-substituted indolines with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Patent CN103189383B details novel biaryl diphosphine ligands enabling cost reduction in pharmaceutical intermediates manufacturing through improved asymmetric catalysis and scalability.
Patent CN1124962A details novel chiral catalysts for high-ee alcohol production, offering scalable routes for API intermediates and cost-effective manufacturing solutions.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.